logo
Home Publications About the Authors
About the Authors
Deutsch Englisch
Contact Impressum Data Protection Login
logo
Home Publications About the Authors
About the Authors
Deutsch Englisch
Contact Impressum Data Protection Login

KONTAKTINFORMATIONEN

 

Deutsches Arzneiprüfungsinstitut e. V. (DAPI)
Heidestraße 7
10557 Berlin
Tel. +49 30 / 40004-572
Fax +49 30 / 40004-573
Internet: www.dapi.de
E-Mail: info(at)dapi.de

Dippel, Franz-Werner
Sanofi-Aventis Deutschland GmbH
Publications:
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
DAPI
News
Publications
Members